Latest News Royal Society of Chemistry recognises Astex Scientists Astex Drug Candidates to be Presented at the 2008 AACR Annual Meeting Astex Receives IND Approval for its Small Molecule HSP90 Inhibitor AT13387; Astex Announces Extension of Drug Discovery Alliance Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting Astex Drug Candidates to be Featured at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Astex Grants Cytochrome P450 License to GlaxoSmithKline Astex Therapeutics Appoints John Aston Chief Financial Officer Astex patents granted covering the use of key human cytochrome P450 structures Astex Therapeutics initiates clinical trial with investigational anti-cancer drug AT9283 New anti-cancer drug discovery alliance between GlaxoSmithKline, the Wellcome Trust and The Institute of Cancer Research, focused on B-RAF inhibitors, builds on partnership between Astex, the Wellcome Trust, the Institute of Cancer Research and Cancer Research Technology. Astex announces new Chief Executive Officer Astex Therapeutics announces IND approval for novel cancer drug AT9283 Astex announces new drug discovery collaboration with University of Newcastle upon Tyne and Cancer Research Technology Limited Astex grants Cytochrome P450 license to Pfizer Astex Announces New Licensing and Drug Discovery Alliance to Develop Novel Cell Cycle Cancer Drugs Astex announces new drug discovery collaboration with Boehringer Ingelheim AstraZeneca and Astex announce new anti-cancer drug discovery alliance Astex Technology changes name to Astex Therapeutics Astex announces IND approval for novel cancer drug AT7519 Astex announces Clinical Trial Authorization for novel cancer drug AT7519 and plans for two further new drug filings in the next nine months Neil Gallagher, MD PhD, joins Astex as Director of Clinical Development Astex achieves drug discovery milestone with Boehringer Ingelheim Dr Peter Ringrose joins Astex Board Astex granted patent covering use of crystal structure of human cytochrome P450 3A4, the most important drug metabolising enzyme in man Astex chosen by the World Economic Forum as a Technology Pioneer for 2005 Astex awarded The Sunday Times Microsoft Tech Track 100 Research and Development Award 2004 Astex achieves drug discovery collaboration success with Schering AG Astex strengthens management team - Martin Buckland joins as Senior Vice President, Business Development Astex ranked top biotech company for the second year running in The Sunday Times Microsoft Tech Track 100 Astex reveals structure of key drug metabolizing enzyme - cytochrome P450 3A4 - in Science Astex extends research collaboration with Aventis Astex achieves second milestone in Alzheimer’s drug discovery collaboration with AstraZeneca Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology announce major cancer drug discovery collaboration Astex announces drug discovery alliance with Boehringer Ingelheim Astex strengthens oncology expertise - Director of Oncology joins management team Astex announces merger with metaGen Pharmaceuticals GmbH and improves cash position by £23m Astex and Cambridge Crystallographic Data Centre announce further research collaboration Astex ranked in the top 20 of The Sunday Times ARM Tech Track 100 Astex achieves milestone in Alzheimer’s drug discovery collaboration with AstraZeneca Astex and Fujisawa announce structure-based drug discovery agreement Astex reveals the first structure of a Human Cytochrome P450 involved in drug metabolism Astex Technology’s new research and development facility opened by Lord Sainsbury Astex extends research collaboration with AstraZeneca Astex discovers novel form of a key protein implicated in diabetes and obesity Astex and Schering AG announce multi-target drug discovery alliance with focus on cancer drugs Astex announces drug discovery collaboration with the Institute of Cancer Research and Cancer Research Technology Astex announces Alzheimer’s drug discovery collaboration with AstraZeneca Astex appoints Director of Medicinal Chemistry Astex reviews key achievements in 2002 Astex expands patent portfolio Astex joins structural biology partnership at the European Synchrotron Radiation Facility Astex determines structure of the key drug metabolising enzyme – human cytochrome P450 3A4 Astex announces drug discovery collaboration with Mitsubishi Pharma Corporation Astex Technology appoints Dr Lyn Leaper as Vice President of Intellectual Property Aventis Pharmaceuticals makes milestone payment to Astex in cytochrome P450 collaboration Tornado Insider Top 100 Astex announces structure-based drug discovery agreement with Mitsubishi Pharma Corporation TIME - Europe's Hottest Tech Firms Astex announces appointment of Vice President of Biology Astex and Maybridge announce exclusive lead discovery collaboration Peter Fellner joins Astex as Chairman Astex utilizes Daylight chemical information software for drug discovery Astex announces structure-based drug discovery collaboration with Aventis Pharmaceuticals Astex receives milestone payment from AstraZeneca for human cytochrome P450 program Astex appoints Director of Biophysics Astex announces plans for new, purpose-built facility on Cambridge Science Park. Astex solves first structure of a human cytochrome P450, a key enzyme in drug metabolism and toxicity. Astex raises an additional £5.7m ($8.1m) Astex Technology Appoints Jon S. Saxe to Board of Directors Astex Technology acquires novel robotic technology for high throughput x-ray crystallography. Astex Technology joins Global Phasing consortium to collaborate on macromolecular crystal structure determination projects Astex and Daresbury Laboratory announce agreement to accelerate drug discovery using high capacity X-ray crystallography. Astex raises £22.7m for structure-based drug discovery research Astex and AstraZeneca announce structural biology research agreement on cytochrome P450 Astex announces structure-based drug development program on cytochrome P450 Astex Technology announces appointment of Vice President of Drug Discovery and Commercial Director Astex Technology announces an exclusive research collaboration with Cambridge Crystallographic Data Centre Astex Technology announces the appointment of leading scientists to key positions within the company Astex Technology obtains access to leading edge X-ray detector technology and synchrotron light source Anne Campbell MP opens new headquarters for Astex Technology Ltd Astex Technology expands its Scientific Advisory Board and appoints Professor Steven Ley and Professor Robert Stroud Astex announces a new collaboration with Janssen Research Foundation Astex Technology appoints Chief Executive Astex Technology announces first deal with a major pharmaceutical company Dr Tim Rink joins the Board of Astex Technology Dr Simon Campbell joins the Board of Astex Technology New Cambridge-based biotech start-up
